Saturday, December 19, 2015

SYM/BBG 12/18 Harvoni scripts were 6937 + sovaldi 2046 = 8983, Harvoni NRX=2670

These are USA numbers only!!! 

Using Symphony/BBG data!

Harvoni is approved in Europe ,Canada , and Japan(7/7/15) too.
Sovaldi is approved in Europe and Japan (3/26/15) and Canada too. 

============================================================================

Harvoni: Prescr. figures for wk ending 12/11 (Symphony/BBG) : TRx@ 6,937 NRx@ 2,670.
Sovaldi: Prescr. figures for wk ending 12/11 (Symphony/BBG) : TRx@ 2,046 NRx@ 680.
Viekira:  Prescr. figures for wk ending 11/6 (Symphony/BBG) : TRx@ 1069 NRx@ 469.

12% Nrx  ABBV HPC market
11% Trx ABBV HPC market

===========================================================================

2014
Q1 sovaldi = $2.27 billion / $1.44 eps / revenue $5.00 billion / Trx xxxx       / $2.73 billion other / 29%
Q2 sovaldi = $3.48 billion / $2.36 eps / revenue $6.53 billion / Trx 101,600 / $3.05 billion other / 36%
Q3 sovaldi = $2.80 billion / $2.05 eps / revenue $6.04 billion / Trx  84,196 /  $3.24 billion other / 34%
Q4 HCV   = $3.83 billion / $2.43 eps / revenue $7.31 billion / Trx  96,333 /  $3.48 billion other / 33.5%
2015
Q1 HCV   = $3.44 billion / $2.94 eps / revenue $7.60 billion / Trx 136,849/  $4.16 billion other / 38.5%
$25,137 per traceable TRX Q1 2015.
Q2 HCV   = $3.44 billion / $3.15 eps / revenue $8.20 billion / Trx 150,100/  $4.75 billion other / 38.5%
$22,650 per traceable TRX Q2 2015.
Q3 HCV   = $3.23 billion / $3.22 eps / revenue $8.20 billion / Trx 129,550/  $4.97 billion other / 39.2%
$24,932 per traceable TRX Q3 2015.

BUYBACK is driving EPS UP as noted in 33.5% vs 39.2% EPS ratio. Also worldwide distribution is pushing it up also, as profits go up and costs come down.

================================================================
Q4 2015 HCV analysts expecting=
$2.80 billion / $2.96 eps / revenue $8.07 billion expected / Trx 130,000 / $5.27 billion other / 36.5%
$18,500 per traceable TRX = 10,000 TRX
vs.
Tracking at Q4 HCV
Q4 HCV guess = 
$2.70 billion / $3.11 eps guess / revenue $8.1 billion guess / Trx 119,550 / $5.40 billion other / 38.5% 9200 TRX wk
$22,650 per traceable TRX Q2 2015. Smallest number chosen!

================================================================

OCT  9473  for both TRX = 42632 TRX 4.5 weeks
NOV 9140  for both TRX = 36562 TRX 4 weeks
?DEC 9000 for both TRX = 40500 TRX 4.5 weeks
?Total=119,550 TRX / 13= 9207 wk 

 ?= waiting for data

NEEDS TO BE Q4 15:
AVERAGE = 9192 13 weeks= 119,500 TRX

Dates are Report dates. actual data is for previous  week!! ex. 11/7 is data from 10/31
=========================================
OCT
10/02  GILD Harvoni's scripts were 7470 + sovaldi 2068 =  9454   TRX- total NRX 4298/2 =4727 
10/09  GILD Harvoni's scripts were 7556 + sovaldi 2121 =  9677   TRX- total NRX 4164 
10/16  GILD Harvoni's scripts were 7564 + sovaldi 2301 =  9865   TRX- total NRX 4232 
10/23  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
10/30  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
average 9473 TRX x 4.5 =42632 TRX 
=============================================
NOV
11/06  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 
11/13  GILD Harvoni's scripts were  6814 + sovaldi 2126 =  8940   TRX- total NRX 3809 
11/20  GILD Harvoni's scripts were  7087 + sovaldi 2242 =  9329   TRX- total NRX 3824 
11/27  GILD Harvoni's scripts were  7000 + sovaldi 2100 =  9100   TRX- total NRX 3700 guess
average 9140 TRX x 4.0 =36562 TRX 
=============================================
DEC
12/04  GILD Harvoni's scripts were  7000 + sovaldi 2100 =  9100   TRX- total NRX 3550 guess
12/11  GILD Harvoni's scripts were 6950 + sovaldi 2050 =  9000   TRX- total NRX 3450 guess
12/18  GILD Harvoni's scripts were 6937 + sovaldi 2046 =  8983   TRX- total NRX 3350 
12/25  GILD Harvoni's scripts were   
12/02  GILD Harvoni's scripts were  
average 9000 TRX x 4.5 =44305 TRX 

==================================================================
Q2 solvaldi sales = EPS 2.36 
Sovaldi3,480,093
at $34231 per RX we get TRX 101,662 /13 = 7820 TRX per week/ 36%
--------------------------------------------------------------------------------------------------------------------
Q3 solvaldi sales =  EPS 2.05
Sovaldi2,796,093
at $33208 per RX we get TRX  84,196 / 13 = 6476 TRX per week/ 34%
--------------------------------------------------------------------------------------------------------------------
Q4 HCV sales = EPS 2.43
Harvoni + sovaldi sales = 3,830,000 
at $39757 per RX we get TRX 96,333 / 13 or 7410 TRX per week/ 33.5%
-------------------------------------------------------------------------------------
Q1 HCV sales = EPS 2.94
Harvoni + sovaldi sales = 3,440,000 
at $25137 per RX we get TRX 136,849 / 13 or 10526 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q2 HCV sales = EPS 3.15
Harvoni + sovaldi sales = 3,440,000 
at $22650 per RX we get TRX 150,100 / 13 or 11546 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q3 HCV sales = EPS 3.22
Harvoni + sovaldi sales = 3,230,000
at $24,932 per RX we get TRX 129,550 / 13 or 9965 TRX per week/ 39.2%

Wednesday, December 16, 2015

Only one cures a problem, Sovaldi does.

Of the drugs below, Sovaldi CURES hepc!

Source: Senate Finance Committee report
The 10 drugs that cost N.C. Medicaid spent the most in 2014

Abilify: $85 million / psychotic conditions such as schizophrenia and bipolar disorder
Sovaldi: $40 million / CURES HEPC
Vyvanse: $37 million /popular stimulants used to treat ADHD
Intuniv: $35 million /used to treat ADHD
Lantus: $28 million /long-acting form of insulin, Diabetes
Adderall: $25 million /popular stimulants used to treat ADHD
Proair: $23 million /Asthma, symptom relief
Concerta: $23 million /popular stimulants used to treat ADHD
Seroquel: $21 million /treat schizophrenia in adults and children
Cymbalta: $21 million /treatment of depression, generalized anxiety disorder

Look at that list! North Carolina Pays for Asmatic ADHD Diabetic patient care of  $285 million a year, NO cures!
ADHD alone is $120 million a year, NO cures! multiply x 50 states and you will see, Sovaldi is a great deal!

http://www.bizjournals.com/triangle/news/2015/12/15/nc-medicaid-expensive-drug-spending.html?ana=yahoo

Saturday, November 28, 2015

SYM/BBG 11/27 Harvoni scripts were 7087 + sovaldi 2242 = 9329, Harvoni NRX=2953

These are USA numbers only!!! 

Using Symphony/BBG data!

Harvoni is approved in Europe ,Canada , and Japan(7/7/15) too.
Sovaldi is approved in Europe and Japan (3/26/15) and Canada too. 

============================================================================

Harvoni: Prescr. figures for wk ending 11/20 (Symphony/BBG) : TRx@ 7,087 NRx@ 2,953.
Sovaldi: Prescr. figures for wk ending 11/20 (Symphony/BBG) : TRx@ 2,242 NRx@ 871.
Viekira:  Prescr. figures for wk ending 11/6 (Symphony/BBG) : TRx@ 1069 NRx@ 469.

12% Nrx  ABBV HPC market
11% Trx ABBV HPC market

===========================================================================

2014
Q1 sovaldi = $2.27 billion / $1.44 eps / revenue $5.00 billion / Trx xxxx       / $2.73 billion other / 29%
Q2 sovaldi = $3.48 billion / $2.36 eps / revenue $6.53 billion / Trx 101,600 / $3.05 billion other / 36%
Q3 sovaldi = $2.80 billion / $2.05 eps / revenue $6.04 billion / Trx  84,196 /  $3.24 billion other / 34%
Q4 HCV   = $3.83 billion / $2.43 eps / revenue $7.31 billion / Trx  96,333 /  $3.48 billion other / 33.5%
2015
Q1 HCV   = $3.44 billion / $2.94 eps / revenue $7.60 billion / Trx 136,849/  $4.16 billion other / 38.5%
$25,137 per traceable TRX Q1 2015.
Q2 HCV   = $3.44 billion / $3.15 eps / revenue $8.20 billion / Trx 150,100/  $4.75 billion other / 38.5%
$22,650 per traceable TRX Q2 2015.
Q3 HCV   = $3.23 billion / $3.22 eps / revenue $8.20 billion / Trx 129,550/  $4.97 billion other / 39.2%
$24,932 per traceable TRX Q3 2015.

BUYBACK is driving EPS UP as noted in 33.5% vs 39.2% EPS ratio. Also worldwide distribution is pushing it up also, as profits go up and costs come down.

================================================================
Q4 2015 HCV analysts expecting=
$2.81 billion / $2.96 eps / revenue $8.01 billion expected / Trx 130,000 / $5.2 billion other / 36.5%
$18,500 per traceable TRX = 10,000 TRX
vs.
Tracking at Q4 HCV
Q4 HCV guess = 
$2.70 billion / $3.04 eps guess / revenue $8.01 billion guess / Trx 129,550 / $5.31 billion other / 38.5% 9833 TRX wk
$24,932 per traceable TRX Q3 2015.

================================================================

OCT  9473  for both TRX = 42632 TRX 4.5 weeks
?NOV  10176 for both TRX = 40706 TRX 4 weeks
?DEC   9895 for both TRX = 44305 TRX 4.5 weeks
?Total=129,550 TRX / 13= 9965 wk 

 ?= waiting for data

NEEDS TO BE Q4 15:
AVERAGE = 9833 13 weeks= 127,800 TRX

Dates are Report dates. actual data is for previous  week!! ex. 11/7 is data from 10/31
=========================================
OCT
10/02  GILD Harvoni's scripts were 7470 + sovaldi 2068 =  9454   TRX- total NRX 4298/2 =4727 
10/09  GILD Harvoni's scripts were 7556 + sovaldi 2121 =  9677   TRX- total NRX 4164 
10/16  GILD Harvoni's scripts were 7564 + sovaldi 2301 =  9865   TRX- total NRX 4232 
10/23  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
10/30  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
average 9473 TRX x 4.5 =42632 TRX 
=============================================
NOV
11/06  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 
11/13  GILD Harvoni's scripts were  6814 + sovaldi 2126 =  8940   TRX- total NRX 3809 
11/20  GILD Harvoni's scripts were  7087 + sovaldi 2242 =  9329   TRX- total NRX 3824 
11/27  GILD Harvoni's scripts were   
average 10176 TRX x 4.0 =40706 TRX 
=============================================
DEC
12/04  GILD Harvoni's scripts were   
12/11  GILD Harvoni's scripts were  
12/18  GILD Harvoni's scripts were 
12/25  GILD Harvoni's scripts were   
12/02  GILD Harvoni's scripts were  
average 9845 TRX x 4.5 =44305 TRX 

==================================================================
Q2 solvaldi sales = EPS 2.36 
Sovaldi3,480,093
at $34231 per RX we get TRX 101,662 /13 = 7820 TRX per week/ 36%
--------------------------------------------------------------------------------------------------------------------
Q3 solvaldi sales =  EPS 2.05
Sovaldi2,796,093
at $33208 per RX we get TRX  84,196 / 13 = 6476 TRX per week/ 34%
--------------------------------------------------------------------------------------------------------------------
Q4 HCV sales = EPS 2.43
Harvoni + sovaldi sales = 3,830,000 
at $39757 per RX we get TRX 96,333 / 13 or 7410 TRX per week/ 33.5%
-------------------------------------------------------------------------------------
Q1 HCV sales = EPS 2.94
Harvoni + sovaldi sales = 3,440,000 
at $25137 per RX we get TRX 136,849 / 13 or 10526 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q2 HCV sales = EPS 3.15
Harvoni + sovaldi sales = 3,440,000 
at $22650 per RX we get TRX 150,100 / 13 or 11546 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q3 HCV sales = EPS 3.22
Harvoni + sovaldi sales = 3,230,000
at $24,932 per RX we get TRX 129,550 / 13 or 9965 TRX per week/ 39.2%

Friday, November 20, 2015

SYM/BBG 11/20 Harvoni scripts were 6814 + sovaldi 2126 = 8940, Harvoni NRX=2991

These are USA numbers only!!! 

Using Symphony/BBG data!

Harvoni is approved in Europe ,Canada , and Japan(7/7/15) too.
Sovaldi is approved in Europe and Japan (3/26/15) and Canada too. 

============================================================================

Harvoni: Prescr. figures for wk ending 11/13 (Symphony/BBG) :TRx@ 6,841 NRx@ 2,991
Sovaldi: Prescr. figures for wk ending 11/13 (Symphony/BBG) : TRx@ 2,126 NRx@ 818
Viekira: 11/13 TRx@ 993 NRx@ 444 wk ending (12% share of total HCV NRx).

12% Nrx  ABBV HPC market
11% Trx ABBV HPC market

===========================================================================

2014
Q1 sovaldi = $2.27 billion / $1.44 eps / revenue $5.00 billion / Trx xxxx       / $2.73 billion other / 29%
Q2 sovaldi = $3.48 billion / $2.36 eps / revenue $6.53 billion / Trx 101,600 / $3.05 billion other / 36%
Q3 sovaldi = $2.80 billion / $2.05 eps / revenue $6.04 billion / Trx  84,196 /  $3.24 billion other / 34%
Q4 HCV   = $3.83 billion / $2.43 eps / revenue $7.31 billion / Trx  96,333 /  $3.48 billion other / 33.5%
2015
Q1 HCV   = $3.44 billion / $2.94 eps / revenue $7.60 billion / Trx 136,849/  $4.16 billion other / 38.5%
$25,137 per traceable TRX Q1 2015.
Q2 HCV   = $3.44 billion / $3.15 eps / revenue $8.20 billion / Trx 150,100/  $4.75 billion other / 38.5%
$22,650 per traceable TRX Q2 2015.
Q3 HCV   = $3.23 billion / $3.22 eps / revenue $8.20 billion / Trx 129,550/  $4.97 billion other / 39.2%
$24,932 per traceable TRX Q3 2015.

BUYBACK is driving EPS UP as noted in 33.5% vs 39.2% EPS ratio. Also worldwide distribution is pushing it up also, as profits go up and costs come down.

================================================================
Q4 2015 HCV analysts expecting=
$2.81 billion / $2.96 eps / revenue $8.01 billion expected / Trx 130,000 / $5.2 billion other / 36.5%
$18,500 per traceable TRX = 10,000 TRX
vs.
Tracking at Q4 HCV
Q4 HCV guess = 
$2.70 billion / $3.04 eps guess / revenue $8.01 billion guess / Trx 129,550 / $5.31 billion other / 38.5% 9833 TRX wk
$24,932 per traceable TRX Q3 2015.

================================================================

OCT  9473  for both TRX = 42632 TRX 4.5 weeks
?NOV  10176 for both TRX = 40706 TRX 4 weeks
?DEC   9895 for both TRX = 44305 TRX 4.5 weeks
?Total=129,550 TRX / 13= 9965 wk 

 ?= waiting for data

NEEDS TO BE Q4 15:
AVERAGE = 9833 13 weeks= 127,800 TRX

Dates are Report dates. actual data is for previous  week!! ex. 11/7 is data from 10/31
=========================================
OCT
10/02  GILD Harvoni's scripts were 7470 + sovaldi 2068 =  9454   TRX- total NRX 4298/2 =4727 
10/09  GILD Harvoni's scripts were 7556 + sovaldi 2121 =  9677   TRX- total NRX 4164 
10/16  GILD Harvoni's scripts were 7564 + sovaldi 2301 =  9865   TRX- total NRX 4232 
10/23  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
10/30  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
average 9473 TRX x 4.5 =42632 TRX 
=============================================
NOV
11/06  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 
11/13  GILD Harvoni's scripts were  6814 + sovaldi 2126 =  8940   TRX- total NRX 3809 
11/20  GILD Harvoni's scripts were    
11/27  GILD Harvoni's scripts were   
average 10176 TRX x 4.0 =40706 TRX 
=============================================
DEC
12/04  GILD Harvoni's scripts were   
12/11  GILD Harvoni's scripts were  
12/18  GILD Harvoni's scripts were 
12/25  GILD Harvoni's scripts were   
12/02  GILD Harvoni's scripts were  
average 9845 TRX x 4.5 =44305 TRX 

==================================================================
Q2 solvaldi sales = EPS 2.36 
Sovaldi3,480,093
at $34231 per RX we get TRX 101,662 /13 = 7820 TRX per week/ 36%
--------------------------------------------------------------------------------------------------------------------
Q3 solvaldi sales =  EPS 2.05
Sovaldi2,796,093
at $33208 per RX we get TRX  84,196 / 13 = 6476 TRX per week/ 34%
--------------------------------------------------------------------------------------------------------------------
Q4 HCV sales = EPS 2.43
Harvoni + sovaldi sales = 3,830,000 
at $39757 per RX we get TRX 96,333 / 13 or 7410 TRX per week/ 33.5%
-------------------------------------------------------------------------------------
Q1 HCV sales = EPS 2.94
Harvoni + sovaldi sales = 3,440,000 
at $25137 per RX we get TRX 136,849 / 13 or 10526 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q2 HCV sales = EPS 3.15
Harvoni + sovaldi sales = 3,440,000 
at $22650 per RX we get TRX 150,100 / 13 or 11546 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q3 HCV sales = EPS 3.22
Harvoni + sovaldi sales = 3,230,000
at $24,932 per RX we get TRX 129,550 / 13 or 9965 TRX per week/ 39.2%

Monday, November 16, 2015

SYM/BBG 11/13 Harvoni scripts were 7104 + sovaldi 2089 = 9193, Harvoni NRX=3100

These are USA numbers only!!! 

Using Symphony/BBG data!

Harvoni is approved in Europe ,Canada , and Japan(7/7/15) too.
Sovaldi is approved in Europe and Japan (3/26/15) and Canada too. 

============================================================================

Harvoni: Prescr. figures for wk ending 11/6 (Symphony/BBG) : TRx@ 7,104 NRx@ 3,100.
Sovaldi: Prescr. figures for wk ending 11/6 (Symphony/BBG) : TRx@ 2,089 NRx@ 814.
Viekira: 10/4 TRx 589, -9% wk/wk, and NRx 249, -12% wk/wk (6.8% share of total HCV NRx).

6% Nrx  ABBV HPC market
7% Trx ABBV HPC market

===========================================================================

2014
Q1 sovaldi = $2.27 billion / $1.44 eps / revenue $5.00 billion / Trx xxxx       / $2.73 billion other / 29%
Q2 sovaldi = $3.48 billion / $2.36 eps / revenue $6.53 billion / Trx 101,600 / $3.05 billion other / 36%
Q3 sovaldi = $2.80 billion / $2.05 eps / revenue $6.04 billion / Trx  84,196 /  $3.24 billion other / 34%
Q4 HCV   = $3.83 billion / $2.43 eps / revenue $7.31 billion / Trx  96,333 /  $3.48 billion other / 33.5%
2015
Q1 HCV   = $3.44 billion / $2.94 eps / revenue $7.60 billion / Trx 136,849/  $4.16 billion other / 38.5%
$25,137 per traceable TRX Q1 2015.
Q2 HCV   = $3.44 billion / $3.15 eps / revenue $8.20 billion / Trx 150,100/  $4.75 billion other / 38.5%
$22,650 per traceable TRX Q2 2015.
Q3 HCV   = $3.23 billion / $3.22 eps / revenue $8.20 billion / Trx 129,550/  $4.97 billion other / 39.2%
$24,932 per traceable TRX Q3 2015.

BUYBACK is driving EPS UP as noted in 33.5% vs 39.2% EPS ratio. Also worldwide distribution is pushing it up also, as profits go up and costs come down.

================================================================
Q4 2015 HCV analysts expecting=
$2.81 billion / $2.96 eps / revenue $8.01 billion expected / Trx 130,000 / $5.2 billion other / 36.5%
$18,500 per traceable TRX = 10,000 TRX
vs.
Tracking at Q4 HCV
Q4 HCV guess = 
$2.70 billion / $3.04 eps guess / revenue $8.01 billion guess / Trx 129,550 / $5.31 billion other / 38.5% 9833 TRX wk
$24,932 per traceable TRX Q3 2015.

================================================================

OCT  9473  for both TRX = 42632 TRX 4.5 weeks
?NOV  10176 for both TRX = 40706 TRX 4 weeks
?DEC   9895 for both TRX = 44305 TRX 4.5 weeks
?Total=129,550 TRX / 13= 9965 wk 

 ?= waiting for data

NEEDS TO BE Q4 15:
AVERAGE = 9833 13 weeks= 127,800 TRX

Dates are Report dates. actual data is for previous  week!! ex. 11/7 is data from 10/31
=========================================
OCT
10/02  GILD Harvoni's scripts were 7470 + sovaldi 2068 =  9454   TRX- total NRX 4298/2 =4727 
10/09  GILD Harvoni's scripts were 7556 + sovaldi 2121 =  9677   TRX- total NRX 4164 
10/16  GILD Harvoni's scripts were 7564 + sovaldi 2301 =  9865   TRX- total NRX 4232 
10/23  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
10/30  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 guess 
average 9473 TRX x 4.5 =42632 TRX 
=============================================
NOV
11/06  GILD Harvoni's scripts were  7104 + sovaldi 2089 =  9193   TRX- total NRX 3914 
11/13  GILD Harvoni's scripts were    
11/20  GILD Harvoni's scripts were    
11/27  GILD Harvoni's scripts were   
average 10176 TRX x 4.0 =40706 TRX 
=============================================
DEC
12/04  GILD Harvoni's scripts were   
12/11  GILD Harvoni's scripts were  
12/18  GILD Harvoni's scripts were 
12/25  GILD Harvoni's scripts were   
12/02  GILD Harvoni's scripts were  
average 9845 TRX x 4.5 =44305 TRX 

==================================================================
Q2 solvaldi sales = EPS 2.36 
Sovaldi3,480,093
at $34231 per RX we get TRX 101,662 /13 = 7820 TRX per week/ 36%
--------------------------------------------------------------------------------------------------------------------
Q3 solvaldi sales =  EPS 2.05
Sovaldi2,796,093
at $33208 per RX we get TRX  84,196 / 13 = 6476 TRX per week/ 34%
--------------------------------------------------------------------------------------------------------------------
Q4 HCV sales = EPS 2.43
Harvoni + sovaldi sales = 3,830,000 
at $39757 per RX we get TRX 96,333 / 13 or 7410 TRX per week/ 33.5%
-------------------------------------------------------------------------------------
Q1 HCV sales = EPS 2.94
Harvoni + sovaldi sales = 3,440,000 
at $25137 per RX we get TRX 136,849 / 13 or 10526 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q2 HCV sales = EPS 3.15
Harvoni + sovaldi sales = 3,440,000 
at $22650 per RX we get TRX 150,100 / 13 or 11546 TRX per week/ 38.5%
-------------------------------------------------------------------------------------
Q3 HCV sales = EPS 3.22
Harvoni + sovaldi sales = 3,230,000
at $24,932 per RX we get TRX 129,550 / 13 or 9965 TRX per week/ 39.2%